N-(2-furylmethyl)-N-[(5-methoxy-1H-indol-3-yl)methyl]amine - Names and Identifiers
N-(2-furylmethyl)-N-[(5-methoxy-1H-indol-3-yl)methyl]amine - Physico-chemical Properties
Molecular Formula | C15H16N2O2
|
Molar Mass | 256.3 |
Storage Condition | Room Temprature |
Sensitive | Irritant |
MDL | MFCD11982921 |
N-(2-furylmethyl)-N-[(5-methoxy-1H-indol-3-yl)methyl]amine - Risk and Safety
N-(2-furylmethyl)-N-[(5-methoxy-1H-indol-3-yl)methyl]amine - Introduction
N-(2-Furylmethyl)-N-[(5-methoxy-1H-indol-3-yl)-methyl]amine is an organic compound with the chemical formula C16H18N2O2.
Nature:
N-(2-Furylmethyl)-N-[(5-methoxy-1H-indol-3-yl)-methyl]amine exists in the form of colorless to pale yellow crystals. It is a soluble in organic solvents (such as ethanol, dimethyl sulfoxide, etc.), insoluble in water.
Use:
N-(2-Furylmethyl)-N-[(5-methoxy-1H-indol-3-yl)-methyl]amine has certain application value in the field of drugs. It is used as an intermediate or raw material, and can be used to synthesize a variety of pharmaceutical compounds, such as anti-cancer drugs and antidepressants.
Preparation Method:
The synthesis method of N-(2-Furylmethyl)-N-[(5-methoxy-1H-indol-3-yl)-methyl]amine can be completed by multi-step reaction. A common synthesis method is to start from 2-oxopentadiene and obtain the target product through amidation, roasting reduction, alkylation and ammoniacal etherification.
Safety Information:
There is a lack of clear literature on the safety information of N-(2-Furylmethyl)-N-[(5-methoxy-1H-indol-3-yl)-methyl]amine. However, as an organic compound, it may have certain acute and chronic toxicity, and care should be taken to avoid direct contact with skin, eyes and mucous membranes. During use, appropriate protective measures should be taken, such as wearing gloves, goggles and protective clothing. If ingestion or inhalation causes discomfort, seek medical attention immediately and bring information about the compound. It is best to refer to the safety data sheet provided by the manufacturer before use.
Last Update:2024-04-09 21:32:52